Follicular Lymphoma
News
Bendamustine-Rituximab Doubles Progression-Free Survival in Indolent Lymphomas
News
The Oncology Report Guide to Cancer Drugs and Devices in 2011
News
Is the US running too many T-cell lymphoma trials?
SAN FRANCISCO—The US currently has 284 open clinical trials enrolling patients with T-cell lymphomas, a fact that is actually detrimental to this...
Conference Coverage
Pregnant Women With Lymphoma Can Have Good Outcomes
Major Finding: Among women with lymphomas diagnosed during pregnancy, the 3-year progression-free survival rates were 76% in women who underwent...
News
Obinutuzumab Equals Rituximab in Relapsed Indolent NHL
Major Finding: The overall investigator-rated response rate among patients with relapsed CD20+ follicular lymphoma assigned to obinutuzumab was 44...
News
Observation Suffices After Rituximab in Low-Burden Follicular Lymphoma
Major Finding: Following 4 weeks of induction with rituximab monotherapy, time to treatment failure was not significantly different between...
News
NICE Expands Chemotherapy Options with Rituximab
Reviews
Underreporting of neutropenic toxicity associated with current treatment regimens for selected hematologic malignancies
News
NCCN Upgrades Rituximab Regimens for Follicular Lymphoma
News
Letter - Acneiform Rash as a Reaction to Radiotherapy in a Breast Cancer Patient
News
Fostamatinib successfully targets the B-cell receptor
The B-cell receptor is present on both normal B cells and malignant B cells. Signaling through this receptor is necessary for B-cell maturation...